Frontier AI company Albert Invent announced a strategic partnership with Kenvue Inc. to accelerate end-to-end R&D efforts across the company’s global portfolio of brands. The partnership enables Kenvue to streamline, digitalize, and accelerate the end-to-end product lifecycle by leveraging Albert Invent’s foundational AI models.
The companies began working together starting in Q1 2025 as part of a multi-year partnership set to drive value for scientists by streamlining hundreds of R&D processes and methodologies across the globe. The focus of the partnership is to augment and accelerate the work of Kenvue’s global workforce of scientists with Albert Invent’s end-to-end AI platform, with the goal of simplifying processes to gain efficiencies both inside and outside of the lab and allowing these incredible scientists to meet evolving consumer needs with even greater impact.
“While we have many digitally-led initiatives, our collaboration with Albert Invent is 100% focused on enhancing how our scientists create products for our consumers,” said Dave Lutness, Head of R&D Digital Capabilities and Platforms at Kenvue. “With the expertise both at Kenvue and with Albert Invent, we are integrating AI into the work we do every day, in service of our brands that billions of people have come to find essential in their lives.”
Leveraging a proprietary AI engine trained on over 15 million molecular structures, Albert Invent empowers scientists to design safer, higher-performing products at unprecedented speed. The platform is trusted by thousands of researchers in more than 30 countries, delivering industry-leading gains in productivity and innovation. By unifying data management, digitalizing workflows, and automating processes, Albert Invent eliminates silos and creates a single source of truth for R&D. This end-to-end approach enhances transparency, strengthens quality control, and streamlines regulatory compliance, accelerating the journey from idea to market.
“Together with Kenvue, we’re using AI to reinvent the future of consumer health,” said Nick Talken, CEO and Co-Founder of Albert Invent. “By combining Kenvue’s scientific expertise with Albert’s AI-powered data platform, we can connect decades of research, uncover entirely new possibilities, and accelerate the creation of products that improve people’s lives around the world.”
To access more business news, visit NJB News Now.
Related Articles: